Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

NCT05562518 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05562518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05562518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Completed
Start date
March 21, 2022
Completion date
March 2, 2026
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, vulvovaginal atrophy